
In late 2020, when the world was searching for a vaccine or cure for COVID-19, the price action in Moderna Inc (NASDAQ:MRNA) was discussed frequently on Benzinga's PreMarket Prep show.
Once the vaccines were developed and the issue ended its miraculous rally, the issue was discussed less and less.